Ridge Augmentation Treatment Using OSSIX® BREEZE vs Jason®
ConditionRidge Augmentation
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorDatum Dental LTD
About this trial
This is a prospective randomized controlled parallel trial. The aim of this study is to evaluate bone formation and soft tissue healing after 4 and 8 months in patients with ridge deficiencies in simultaneous implantation approach. The trial will compare a (sugar cross linked) - SCL pericardium membrane OSSIX® Breeze vs native pericardium membrane (Jason®).
Eligibility criteria
Qualifiers
Males and females, age 18 and above.
General good health (ASA 1 and ASA 2).
Adults with buccal bone defect, who are in need of implant placement, and going through a guided bone regeneration treatment.
Patient needs 1-3 implants.
Disqualifiers
Physical status ASA III or ASA IV.
General contraindications for dental and/or surgical treatments.
Inflammatory and autoimmune disease of the oral cavity.
Patients with known collagen hypersensitivity.
Trial design
Treatments tested in this trial
- OSSIX Breeze
- Jason membrane
Treatment groups
65 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov